Satyajit Ghosh | Neuro Biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Satyajit Ghosh | Neuro Biotechnology | Best Researcher Award

Research Associate at IIT Jodhpur | india

Dr. Satyajit Ghosh, Ph.D. in Bioscience and Bioengineering from the Indian Institute of Technology Jodhpur, is a researcher specializing in neurobiology, extracellular vesicles (EVs), and regenerative medicine. His work focuses on the development of peptide-engineered EVs for targeted neural stem cell delivery, microfluidic neuro-glial co-culture systems, and the mechanistic exploration of EV-mediated neural repair. He integrates advanced molecular and computational tools such as LC-MS/MS proteomics, electrophysiology, and molecular docking to uncover novel neurotherapeutic strategies. Dr. Ghosh has contributed significantly to high-impact journals including ACS Chemical Neuroscience, ACS Applied Materials & Interfaces, Journal of Medicinal Chemistry, and Frontiers in Pharmacology, with 29 publications, 232 citations, and an h-index of 9 in his Scopus profile. His research has led to several patents on peptide-functionalized exosomes, neuroprotective hydrogels, and small molecule neuromodulators, highlighting his translational approach to neuroregeneration. Recognized through awards and fellowships from SERB-India and ISEV, his ongoing work at IIT Jodhpur emphasizes the interface of bioengineering, nanotechnology, and neuroscience for developing next-generation therapeutic interventions in neurodegenerative diseases.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

Ghosh, S., Ghosh, S., Jana, A., Roy, R., & Ghosh, S. (2025). Comprehensive account of exosome isolation from rat substantia nigra for mass spectrometry-based proteomics study. Methods, 241, 150–162.

Ghosh, S., Roy, R., Mukherjee, N., Ghosh, S., Jash, M., Jana, A., & Ghosh, S. (2024). EphA4 targeting peptide-conjugated extracellular vesicles rejuvenate adult neural stem cells and exert therapeutic benefits in aging rats. ACS Chemical Neuroscience, 15(19), 3482–3495.

Ghosh, S., & Ghosh, S. (2022). Extracellular vesicles as disease biomarkers and neurotherapeutics. Frontiers in Pharmacology, 13, 878058.

Jash, M., Ghosh, S., Nandi, S., Adak, A., Roy, R., Bera, A., & Ghosh, S. (2025). Crafting precision: Design and fabrication of a xurography-driven microfluidic platform for exploring neuron culture and targeted drug screening. ACS Chemical Neuroscience.

Nandi, S., Ghosh, S., Garg, S., & Ghosh, S. (2024). Unveiling the human brain on a chip: An odyssey to reconstitute neuronal ensembles and explore plausible applications in neuroscience. ACS Chemical Neuroscience, 15(21), 3828–3847.

Liquan Wu | Neuroscience | Best Researcher Award

Published on by Biotechnology Scientist

Dr. liquan wu | Neuroscience | Best Researcher Award

Senior Neurosurgeron at Renmin Hospital of Wuhan University, China

Dr. Liquan Wu is a distinguished neurosurgeon and neuroscientist, currently serving as a senior surgeon at the Department of Neurosurgery, Renmin Hospital of Wuhan University. With over two decades of dedication to neuroscience and clinical neurosurgery, Dr. Wu has emerged as a leading figure in cerebral ischemia, glioma research, and translational neuromedicine. His academic and research contributions have significantly advanced the understanding of neuroprotection, neuroinflammation, and glioma stem cell biology. Blending clinical excellence with scientific innovation, he continues to bridge bench-side discoveries with bedside applications.

Profile

Scopus

Education:

Dr. Wu’s academic journey reflects a consistent focus on neurosurgical and neuroscience disciplines. He obtained his M.D. from Wuhan University in 2003, followed by a Master’s degree in Neuroscience and Neurosurgery in 2006. To further deepen his expertise, he pursued and completed a Ph.D. in Neuroscience and Neurosurgery from the same institution in 2013. This rigorous academic foundation laid the groundwork for his dynamic career in both clinical and experimental neuroscience.

Experience:

Dr. Wu began his clinical career as a resident in the Department of Neurosurgery at Renmin Hospital, Wuhan University, between 2006 and 2009. He then served as an attending physician and advanced to associate senior surgeon from 2013 to 2021. He currently holds the position of senior surgeon since 2021. Notably, he completed a prestigious research fellowship at Harvard Medical School’s Brigham and Women’s Hospital from 2015 to 2016, enhancing his international exposure to neurosurgical research. His clinical acumen is matched by his technical expertise in brain ischemia models, glioma surgeries, and molecular neurobiology.

Research Interest:

Dr. Wu’s research interests are centered on cerebral ischemia-reperfusion injury, neuroprotection, ferroptosis regulation, and glioma stem cell behavior. He investigates molecular pathways such as PLK1 deubiquitination, Akt activation, and NF-kB modulation, which are crucial in neural injury and repair. He also explores the interface between metabolic profiling and neurosurgical pathology, using advanced proteomics and bioinformatics tools. His innovative studies incorporate machine learning, nanotechnology, and immunomodulation, positioning him at the forefront of translational neuro-oncology.

Award:

Throughout his career, Dr. Wu has been honored with several prestigious research grants and recognitions. He has received the Natural Science Foundation of Hubei Province grant and multiple research project awards from Wuhan University. As both Principal Investigator and Co-Principal Investigator, he has been instrumental in securing and executing projects funded by the National Science Foundation of China, focusing on cancer stem cells, drug resistance in gliomas, and targeted vaccine therapies. These accolades reflect his impact on both scientific discovery and clinical practice.

Publication:

Dr. Wu has contributed extensively to high-impact peer-reviewed journals. A selection of his recent works includes:

  1. Wu LQ et al. (2025). “The deubiquitinase OTUD3 plays a neuroprotective role…” Clin Transl Med, 15(5):e70347.
  2. Ding R, Wu LQ et al. (2024). “Multi-targeted olink proteomics analyses…” Proteome Sci, 22(1):11.
  3. Cheng J, Wu LQ et al. (2024). “Mxene-bpV plays a neuroprotective role…” J Mater Sci Mater Med, 35(1):42.
  4. Ding R, Wu LQ et al. (2024). “Identification of metabolic components…” Rapid Commun Mass Spectrom, 38(14):e9763.
  5. Qin X, Wu LQ et al. (2023). “Identification of anoikis-related genes…” Front Aging Neurosci, 15:1142163.
  6. Cheng J, Wu LQ et al. (2023). “Overexpressing SIRT6 can attenuate the injury…” Neuromolecular Med, 25(1):53-63.
  7. Wu LQ (2022). “Electroacupuncture for Spinal Cord Injury…” Neurospine, 19(3):770-772.
    These publications demonstrate Dr. Wu’s multidisciplinary expertise, ranging from clinical trials and biomarker discovery to neural tissue engineering and systems biology.

Conclusion:

Dr. Liquan Wu exemplifies excellence in both the clinical and scientific arenas of neurosurgery. His robust educational background, international research exposure, and groundbreaking investigations into neuroprotection and glioma therapy mark him as a leading contributor in his field. With impactful publications, funded projects, and clinical service, Dr. Wu is a worthy nominee for the “Best Researcher Award.” His continued dedication to unraveling the molecular intricacies of brain injury and regeneration is not only advancing scientific knowledge but also transforming patient care in neurosurgical practice.